Correlation Between SoftwareONE Holding and Santhera Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both SoftwareONE Holding and Santhera Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SoftwareONE Holding and Santhera Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SoftwareONE Holding AG and Santhera Pharmaceuticals Holding, you can compare the effects of market volatilities on SoftwareONE Holding and Santhera Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SoftwareONE Holding with a short position of Santhera Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SoftwareONE Holding and Santhera Pharmaceuticals.

Diversification Opportunities for SoftwareONE Holding and Santhera Pharmaceuticals

-0.79

Correlation Coefficient

SoftwareONE Holding  Santhera Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between SoftwareONE and Santhera is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding SoftwareONE Holding AG and Santhera Pharmaceuticals Holdi in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santhera Pharmaceuticals and SoftwareONE Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SoftwareONE Holding AG are associated (or correlated) with Santhera Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santhera Pharmaceuticals has no effect on the direction of SoftwareONE Holding i.e., SoftwareONE Holding and Santhera Pharmaceuticals go up and down completely randomly.

Pair Corralation between SoftwareONE Holding and Santhera Pharmaceuticals

Assuming the 90 days trading horizon SoftwareONE Holding AG is expected to generate 1.31 times more return on investment than Santhera Pharmaceuticals. However, SoftwareONE Holding is 1.31 times more volatile than Santhera Pharmaceuticals Holding. It trades about 0.18 of its potential returns per unit of risk. Santhera Pharmaceuticals Holding is currently generating about 0.01 per unit of risk. If you would invest  499.00  in SoftwareONE Holding AG on April 21, 2025 and sell it today you would earn a total of  194.00  from holding SoftwareONE Holding AG or generate 38.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

SoftwareONE Holding AG  vs.  Santhera Pharmaceuticals Holdi

SoftwareONE Holding

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in SoftwareONE Holding AG are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, SoftwareONE Holding showed solid returns over the last few months and may actually be approaching a breakup point.

Santhera Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Santhera Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Santhera Pharmaceuticals is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with SoftwareONE Holding and Santhera Pharmaceuticals

The main advantage of trading using opposite SoftwareONE Holding and Santhera Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SoftwareONE Holding position performs unexpectedly, Santhera Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santhera Pharmaceuticals will offset losses from the drop in Santhera Pharmaceuticals' long position.

The idea behind SoftwareONE Holding AG and Santhera Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.